Literature DB >> 21586716

From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep.

Benjamin Djulbegovic1, Ash Paul.   

Abstract

Mesh：

Year:  2011        PMID： 21586716     DOI： 10.1001/jama.2011.650

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  33 in total

Review 1.  Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Authors:  Kathleen J Ramos; Ranjani Somayaji; David P Nichols; Christopher H Goss
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

2.  Insights from a conference on implementing comparative effectiveness research through shared decision-making.

Authors:  Mary C Politi; Marla L Clayman; Angela Fagerlin; Jamie L Studts; Victor Montori
Journal:  J Comp Eff Res       Date:  2013-01       Impact factor: 1.744

Review 3.  An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.

Authors:  Anil N Makam; Oanh K Nguyen
Journal:  Circulation       Date:  2017-01-10       Impact factor: 29.690

Review 4.  The role of professional societies in limiting indication creep.

Authors:  Kevin R Riggs; Peter A Ubel
Journal:  J Gen Intern Med       Date:  2014-08-05       Impact factor: 5.128

5.  Clinical implementation of an emergency department coronary computed tomographic angiography protocol for triage of patients with suspected acute coronary syndrome.

Authors:  Brian B Ghoshhajra; Richard A P Takx; Pedro V Staziaki; Harshna Vadvala; Phillip Kim; Tomas G Neilan; Nandini M Meyersohn; Daniel Bittner; Sumbal A Janjua; Thomas Mayrhofer; Jeffrey L Greenwald; Quyhn A Truong; Suhny Abbara; David F M Brown; James L Januzzi; Sanjeev Francis; John T Nagurney; Udo Hoffmann
Journal:  Eur Radiol       Date:  2016-11-24       Impact factor: 5.315

6.  Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings.

Authors:  Virendra Kumar; Kavindra Nath; Claudia G Berman; Jongphil Kim; Tawee Tanvetyanon; Alberto A Chiappori; Robert A Gatenby; Robert J Gillies; Edward A Eikman
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

Review 7.  Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making.

Authors:  Mary C Politi; Kathleen Y Wolin; France Légaré
Journal:  J Gen Intern Med       Date:  2013-01-10       Impact factor: 5.128

8.  Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.

Authors:  Natasha K Stout; Larissa Nekhlyudov; Lingling Li; Elisabeth S Malin; Dennis Ross-Degnan; Diana S M Buist; Marjorie A Rosenberg; Marina Alfisher; Suzanne W Fletcher
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

9.  Unintended consequences of Mayo paraneoplastic evaluations.

Authors:  Matthew J Ebright; Shih-Hon Li; Evan Reynolds; James F Burke; Ben R Claytor; Anna Grisold; Mousumi Banerjee; Brian C Callaghan
Journal:  Neurology       Date:  2018-10-26       Impact factor: 9.910

10.  Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 'real-life' studies.

Authors:  Michele Marchioni; Petros Sountoulides; Maida Bada; Sebastiano Rapisarda; Cosimo De Nunzio; Fabiola Raffaella Tamburro; Luigi Schips; Luca Cindolo
Journal:  Ther Adv Urol       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.